Geron Corporation (GERN)
Chart Events
Performance Outlook
| Previous Close | 1.4100 |
| Open | 1.4600 |
| Bid | 1.3900 x 2200 |
| Ask | 1.4000 x 3100 |
| Day's Range | 1.3600 - 1.4600 |
| 52 Week Range | 0.9900 - 2.2300 |
| Volume | |
| Avg. Volume | 2,469,606 |
| Market Cap | 530.313M |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3540 |
| Earnings Date | Aug 15, 2022 - Aug 19, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GERN
Related Research
- Geron CorporationTechnical Assessment: Bearish in the Intermediate-TermVolatility in West Texas Intermediate (WTI) crude oil has started to shrink a bit, with the recent range between the high $90s and $110 and with WTI currently sitting at $105/barrel. After going parabolic in March and reaching $130, crude oil pulled back to $93.50, rallied back to $116.65, and fell to an intraday low of $93 on April 11 before rallying back above $107. It is still possible that WTI is tracing out symmetrical triangle, although the past breakout attempt in early May failed.RatingFair ValueEconomic Moat5 days agoArgus Research
- Motley Fool
Why Geron Stock Is Soaring Today
What happened Shares of Geron Corporation (NASDAQ: GERN) were soaring 15% higher as of 12:04 p.m. ET on Tuesday. The big gain came after the company provided its first-quarter update following the market close on Monday.
- Motley Fool
Geron (GERN) Q1 2022 Earnings Call Transcript
At this time, I would like to welcome everyone to the Geron Corporation first quarter 2022 conference call. Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance, plans, expectations, and other projections including those relating to the therapeutic potential and potential regulatory approval of imetelstat, anticipated clinical and commercial events, and related timelines, the sufficiency of Geron's financial resources, and other statements that are not historical facts.
- Zacks
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
Geron (GERN) delivered earnings and revenue surprises of 18.18% and 23%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
